Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes

Jerzy Mielko; Karol Rawicz-Pruszyński; Katarzyna Sędłak; Katarzyna Gęca; Magdalena Kwietniewska; Wojciech P Polkowski

doi:10.3390/cancers12092387

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes

Cancers (Basel). 2020 Aug 23;12(9):2387. doi: 10.3390/cancers12092387.

Authors

Jerzy Mielko¹, Karol Rawicz-Pruszyński¹, Katarzyna Sędłak¹, Katarzyna Gęca¹, Magdalena Kwietniewska¹, Wojciech P Polkowski¹

Affiliation

¹ Department of Surgical Oncology, Medical University of Lublin, Radziwiłłowska 13 St., 20-080 Lublin, Poland.

Abstract

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a complex, highly specialized procedure used to treat peritoneal surface malignancies (PSM) [...].

Keywords: CRS + HIPEC; learning curve; peritoneal surface malignancies.